Sidewinder Therapeutics
Advancing precision bispecific antibody-drug conjugates to treat cancer
First Investment: 2014
EXIT - Acquisition (Recursion: RXRX)
Vium combined computer vision, machine learning, and sensor technology to build “digital vivariums” that collected noninvasive data on the health of animals used in preclinical research. Recursion acquired the company in 2020.
